ロード中...
Addition of sildenafil in patients with pulmonary arterial hypertension with inadequate response to bosentan monotherapy
BACKGROUND: Pulmonary arterial hypertension (PAH) remains a progressive disease despite improvement when using one of three medication classes: prostanoids, endothelin receptor antagonists or phosphodiesterase-5 inhibitors. Combination therapy has been proposed for patients with unsatisfactory respo...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Pulsus Group Inc
2008
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2682165/ https://ncbi.nlm.nih.gov/pubmed/19107243 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|